Nivolumab vs Sacubitril-Valsartan
Nivolumab vs Sacubitril-Valsartan: Overview
This comparison examines the pharmacological differences between Nivolumab and Sacubitril-Valsartan.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Sacubitril-Valsartan: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Sacubitril-Valsartan β 11.5 hours.
Chemical Properties
Molecular Formula: Sacubitril-Valsartan β C24H29N2O5.
Molecular Weight: Sacubitril-Valsartan β 414.5010 g/mol.
Type: Nivolumab β Antibody; Sacubitril-Valsartan β Small molecule.